Retroviral display in gene therapy, protein engineering, and vaccine development

ACS Chemical Biology

Volumn 6, Issue 1, 2011, Pages 61-74

  Urban, Johannes H ^a   Merten, Christoph A ^b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; DNA VACCINE; EPIDERMAL GROWTH FACTOR RECEPTOR; GLYCOPROTEIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; LIVE VACCINE; MATRIX METALLOPROTEINASE; PLATELET DERIVED GROWTH FACTOR; RETROVIRUS VECTOR; VIRUS ANTIGEN; WART VIRUS VACCINE;

ANTIGEN PRESENTING CELL; BINDING AFFINITY; CATALYSIS; GENE EXPRESSION; GENE THERAPY; HUMAN; IMMUNOGENICITY; LONG TERMINAL REPEAT; MEASLES VIRUS; NONHUMAN; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN ENGINEERING; PROTEIN EXPRESSION; PROTEIN MODIFICATION; RETROVIRUS; REVIEW; UTERINE CERVIX CANCER; VACCINATION; VACCINE PRODUCTION; VIRUS PARTICLE;

CELL MEMBRANE; GENE LIBRARY; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; PROTEIN BINDING; PROTEIN ENGINEERING; PROTEIN PROCESSING, POST-TRANSLATIONAL; RETROVIRIDAE; VACCINES;

MAMMALIA;

EID: 79251504589     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb100285n     Document Type: Review

References (86)

1. Barbas, C. F. (2000) Phage Display: A Laboratory Manual, Cold Spring Harbor Labortory Press, Cold Spring Harbor, NY.
2. Smith, G. P. (1985) Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface Science 228, 1315-1317
3. Kehoe, J. W. and Kay, B. K. (2005) Filamentous phage display in the new millennium Chem. Rev. 105, 4056-4072
4. Sergeeva, A., Kolonin, M. G., Molldrem, J. J., Pasqualini, R., and Arap, W. (2006) Display technologies: application for the discovery of drug and gene delivery agents Adv. Drug Delivery Rev. 58, 1622-1654
5. Hanes, J. and Pluckthun, A. (1997) In vitro selection and evolution of functional proteins by using ribosome display Proc. Natl. Acad. Sci. U.S.A. 94, 4937-4942
6. Roberts, R. W. and Szostak, J. W. (1997) RNA-peptide fusions for the in vitro selection of peptides and proteins Proc. Natl. Acad. Sci. U.S.A. 94, 12297-12302
7. Francisco, J. A., Campbell, R., Iverson, B. L., and Georgiou, G. (1993) Production and fluorescence-activated cell sorting of Escherichia coli expressing a functional antibody fragment on the external surface Proc. Natl. Acad. Sci. U.S.A. 90, 10444-10448
8. Boder, E. T. and Wittrup, K. D. (1997) Yeast surface display for screening combinatorial polypeptide libraries Nat. Biotechnol. 15, 553-557
9. Ho, M., Nagata, S., and Pastan, I. (2006) Isolation of anti-CD22 Fv with high affinity by Fv display on human cells Proc. Natl. Acad. Sci. U.S.A. 103, 9637-9642
10. Buchholz, C. J., Peng, K. W., Morling, F. J., Zhang, J., Cosset, F. L., and Russell, S. J. (1998) In vivo selection of protease cleavage sites from retrovirus display libraries Nat. Biotechnol. 16, 951-954
11. Ernst, W., Grabherr, R., Wegner, D., Borth, N., Grassauer, A., and Katinger, H. (1998) Baculovirus surface display: construction and screening of a eukaryotic epitope library Nucleic Acids Res. 26, 1718-1723
12. Muller, O. J., Kaul, F., Weitzman, M. D., Pasqualini, R., Arap, W., Kleinschmidt, J. A., and Trepel, M. (2003) Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors Nat. Biotechnol. 21, 1040-1046
13. Russell, S. J., Hawkins, R. E., and Winter, G. (1993) Retroviral vectors displaying functional antibody fragments Nucleic Acids Res. 21, 1081-1085
14. Hammarstedt, M., Wallengren, K., Pedersen, K. W., Roos, N., and Garoff, H. (2000) Minimal exclusion of plasma membrane proteins during retroviral envelope formation Proc. Natl. Acad. Sci. U.S.A. 97, 7527-7532
15. Chan, R., Uchil, P. D., Jin, J., Shui, G., Ott, D. E., Mothes, W., and Wenk, M. R. (2008) Retroviruses human immunodeficiency virus and murine leukemia virus are enriched in phosphoinositides J. Virol. 82, 11228-11238
16. Bittner, A., Mitnacht-Kraus, R., and Schnierle, B. S. (2002) Specific transduction of HIV-1 envelope expressing cells by retroviral vectors pseudotyped with hybrid CD4/CXCR4 receptors J. Virol. Methods 104, 83-92
17. Merten, C. A., Stitz, J., Braun, G., Medvedovska, J., Cichutek, K., and Buchholz, C. J. (2006) Fusoselect: cell-cell fusion activity engineered by directed evolution of a retroviral glycoprotein Nucleic Acids Res. 34 e41
18. Fields, B. N., Knipe, D. M., and Howley, P. M. (2007) Fields Virology, 5th ed., Lippincott Williams & Wilkins, Philadelphia.
19. Gheysen, D., Jacobs, E., de Foresta, F., Thiriart, C., Francotte, M., Thines, D., and De Wilde, M. (1989) Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells Cell 59, 103-112
20. Sakalian, M. and Hunter, E. (1998) Molecular events in the assembly of retrovirus particles Adv. Exp. Med. Biol. 440, 329-339
21. Bach, P., Tschape, J. A., Kopietz, F., Braun, G., Baade, J. K., Wiederhold, K. H., Staufenbiel, M., Prinz, M., Deller, T., Kalinke, U., Buchholz, C. J., and Muller, U. C. (2009) Vaccination with Abeta-displaying virus-like particles reduces soluble and insoluble cerebral Abeta and lowers plaque burden in APP transgenic mice J. Immunol. 182, 7613-7624
22. Nikles, D., Bach, P., Boller, K., Merten, C. A., Montrasio, F., Heppner, F. L., Aguzzi, A., Cichutek, K., Kalinke, U., and Buchholz, C. J. (2005) Circumventing tolerance to the prion protein (PrP): vaccination with PrP-displaying retrovirus particles induces humoral immune responses against the native form of cellular PrP J. Virol. 79, 4033-4042
23. Granieri, L., Baret, J. C., Griffiths, A. D., and Merten, C. A. (2010) High-throughput screening of enzymes by retroviral display using droplet-based microfluidics Chem. Biol. 17, 229-235
24. Buchholz, C. J., Duerner, L. J., Funke, S., and Schneider, I. C. (2008) Retroviral display and high throughput screening Comb. Chem. High Throughput Screening 11, 99-110
25. Zhu, P., Liu, J., Bess, J., Jr., Chertova, E., Lifson, J. D., Grise, H., Ofek, G. A., Taylor, K. A., and Roux, K. H. (2006) Distribution and three-dimensional structure of AIDS virus envelope spikes Nature 441, 847-852
26. Forster, F., Medalia, O., Zauberman, N., Baumeister, W., and Fass, D. (2005) Retrovirus envelope protein complex structure in situ studied by cryo-electron tomography Proc. Natl. Acad. Sci. U.S.A. 102, 4729-4734
27. Cronin, J., Zhang, X. Y., and Reiser, J. (2005) Altering the tropism of lentiviral vectors through pseudotyping Curr. Gene Ther. 5, 387-398
28. Sherman, M. P. and Greene, W. C. (2002) Slipping through the door: HIV entry into the nucleus Microbes Infect. 4, 67-73
29. Merten, C. A., Stitz, J., Braun, G., Poeschla, E. M., Cichutek, K., and Buchholz, C. J. (2005) Directed evolution of retrovirus envelope protein cytoplasmic tails guided by functional incorporation into lentivirus particles J. Virol. 79, 834-840
30. Cosset, F. L., Morling, F. J., Takeuchi, Y., Weiss, R. A., Collins, M. K., and Russell, S. J. (1995) Retroviral retargeting by envelopes expressing an N-terminal binding domain J. Virol. 69, 6314-6322
31. Waehler, R., Russell, S. J., and Curiel, D. T. (2007) Engineering targeted viral vectors for gene therapy Nat. Rev. Genet. 8, 573-587
32. Chu, T. H. and Dornburg, R. (1997) Toward highly efficient cell-type-specific gene transfer with retroviral vectors displaying single-chain antibodies J. Virol. 71, 720-725
33. Zhao, Y., Zhu, L., Lee, S., Li, L., Chang, E., Soong, N. W., Douer, D., and Anderson, W. F. (1999) Identification of the block in targeted retroviral-mediated gene transfer Proc. Natl. Acad. Sci. U.S.A. 96, 4005-4010
34. Merten, C. A., Engelstaedter, M., Buchholz, C. J., and Cichutek, K. (2003) Displaying epidermal growth factor on spleen necrosis virus-derived targeting vectors Virology 305, 106-114
35. Curran, S. and Murray, G. I. (1999) Matrix metalloproteinases in tumour invasion and metastasis J. Pathol. 189, 300-308
36. Kessenbrock, K., Plaks, V., and Werb, Z. (2010) Matrix metalloproteinases: regulators of the tumor microenvironment Cell 141, 52-67
37. Peng, K. W., Morling, F. J., Cosset, F. L., Murphy, G., and Russell, S. J. (1997) A gene delivery system activatable by disease-associated matrix metalloproteinases Hum. Gene Ther. 8, 729-738
38. Solly, S. K., Nguyen, T. H., Weber, A., and Horellou, P. (2005) Targeting of c-Met and urokinase expressing human glioma cell lines by retrovirus vector displaying single-chain variable fragment antibody Cancer Biol. Ther. 4, 987-992
39. Schneider, R. M., Medvedovska, Y., Hartl, I., Voelker, B., Chadwick, M. P., Russell, S. J., Cichutek, K., and Buchholz, C. J. (2003) Directed evolution of retroviruses activatable by tumour-associated matrix metalloproteases Gene Ther. 10, 1370-1380
40. Morling, F. J., Peng, K. W., Cosset, F. L., and Russell, S. J. (1997) Masking of retroviral envelope functions by oligomerizing polypeptide adaptors Virology 234, 51-61
41. Hartl, I., Schneider, R. M., Sun, Y., Medvedovska, J., Chadwick, M. P., Russell, S. J., Cichutek, K., and Buchholz, C. J. (2005) Library-based selection of retroviruses selectively spreading through matrix metalloprotease-positive cells Gene Ther. 12, 918-926
42. Duerner, L. J., Schwantes, A., Schneider, I. C., Cichutek, K., and Buchholz, C. J. (2008) Cell entry targeting restricts biodistribution of replication-competent retroviruses to tumour tissue Gene Ther. 15, 1500-1510
43. Bupp, K. and Roth, M. J. (2002) Altering retroviral tropism using a random-display envelope library Mol. Ther. 5, 329-335
44. Bupp, K. and Roth, M. J. (2003) Targeting a retroviral vector in the absence of a known cell-targeting ligand Hum. Gene Ther. 14, 1557-1564
45. Bupp, K., Sarangi, A., and Roth, M. J. (2005) Probing sequence variation in the receptor-targeting domain of feline leukemia virus envelope proteins with peptide display libraries J. Virol. 79, 1463-1469
46. Sarangi, A., Bupp, K., and Roth, M. J. (2007) Identification of a retroviral receptor used by an envelope protein derived by peptide library screening Proc. Natl. Acad. Sci. U.S.A. 104, 11032-11037
47. Mazari, P. M., Linder-Basso, D., Sarangi, A., Chang, Y., and Roth, M. J. (2009) Single-round selection yields a unique retroviral envelope utilizing GPR172A as its host receptor Proc. Natl. Acad. Sci. U.S.A. 106, 5848-5853
48. Soong, N. W., Nomura, L., Pekrun, K., Reed, M., Sheppard, L., Dawes, G., and Stemmer, W. P. (2000) Molecular breeding of viruses Nat. Genet. 25, 436-439
49. Vongpunsawad, S., Oezgun, N., Braun, W., and Cattaneo, R. (2004) Selectively receptor-blind measles viruses: Identification of residues necessary for SLAM- or CD46-induced fusion and their localization on a new hemagglutinin structural model J. Virol. 78, 302-313
50. Nakamura, T., Peng, K. W., Harvey, M., Greiner, S., Lorimer, I. A., James, C. D., and Russell, S. J. (2005) Rescue and propagation of fully retargeted oncolytic measles viruses Nat. Biotechnol. 23, 209-214
51. Nakamura, T., Peng, K. W., Vongpunsawad, S., Harvey, M., Mizuguchi, H., Hayakawa, T., Cattaneo, R., and Russell, S. J. (2004) Antibody-targeted cell fusion Nat. Biotechnol. 22, 331-336
52. Funke, S., Maisner, A., Muhlebach, M. D., Koehl, U., Grez, M., Cattaneo, R., Cichutek, K., and Buchholz, C. J. (2008) Targeted cell entry of lentiviral vectors Mol. Ther. 16, 1427-1436
53. Frecha, C., Costa, C., Negre, D., Gauthier, E., Russell, S. J., Cosset, F. L., and Verhoeyen, E. (2008) Stable transduction of quiescent T cells without induction of cycle progression by a novel lentiviral vector pseudotyped with measles virus glycoproteins Blood 112, 4843-4852
54. Frecha, C., Costa, C., Levy, C., Negre, D., Russell, S. J., Maisner, A., Salles, G., Peng, K. W., Cosset, F. L., and Verhoeyen, E. (2009) Efficient and stable transduction of resting B lymphocytes and primary chronic lymphocyte leukemia cells using measles virus gp displaying lentiviral vectors Blood 114, 3173-3180
55. Anliker, B., Abel, T., Kneissl, S., Hlavaty, J., Caputi, A., Brynza, J., Schneider, I. C., Munch, R. C., Petznek, H., Kontermann, R. E., Koehl, U., Johnston, I. C., Keinanen, K., Muller, U. C., Hohenadl, C., Monyer, H., Cichutek, K., and Buchholz, C. J. (2010) Specific gene transfer to neurons, endothelial cells and hematopoietic progenitors with lentiviral vectors Nat. Methods 7, 929-935
56. Einfeld, D. and Hunter, E. (1988) Oligomeric structure of a prototype retrovirus glycoprotein Proc. Natl. Acad. Sci. U.S.A. 85, 8688-8692
57. Rodi, D. J., Soares, A. S., and Makowski, L. (2002) Quantitative assessment of peptide sequence diversity in M13 combinatorial peptide phage display libraries J. Mol. Biol. 322, 1039-1052
58. Khare, P. D., Rosales, A. G., Bailey, K. R., Russell, S. J., and Federspiel, M. J. (2003) Epitope selection from an uncensored peptide library displayed on avian leukosis virus Virology 315, 313-321
59. Urban, J. H., Schneider, R. M., Compte, M., Finger, C., Cichutek, K., Alvarez-Vallina, L., and Buchholz, C. J. (2005) Selection of functional human antibodies from retroviral display libraries Nucleic Acids Res. 33 e35
60. Taube, R., Zhu, Q., Xu, C., Diaz-Griffero, F., Sui, J., Kamau, E., Dwyer, M., Aird, D., and Marasco, W. A. (2008) Lentivirus display: stable expression of human antibodies on the surface of human cells and virus particles PLoS One 3 e3181
61. Noad, R. and Roy, P. (2003) Virus-like particles as immunogens Trends Microbiol. 11, 438-444
62. DAndrilli, G., Bovicelli, A., and Giordano, A. (2010) HPV vaccines: state of the art J. Cell Physiol. 224, 601-604
63. Bachmann, M. F., Rohrer, U. H., Kundig, T. M., Burki, K., Hengartner, H., and Zinkernagel, R. M. (1993) The influence of antigen organization on B cell responsiveness Science 262, 1448-1451
64. Gamvrellis, A., Leong, D., Hanley, J. C., Xiang, S. D., Mottram, P., and Plebanski, M. (2004) Vaccines that facilitate antigen entry into dendritic cells Immunol. Cell. Biol. 82, 506-516
65. Deml, L., Speth, C., Dierich, M. P., Wolf, H., and Wagner, R. (2005) Recombinant HIV-1 Pr55gag virus-like particles: potent stimulators of innate and acquired immune responses Mol. Immunol. 42, 259-277
66. Young, K. R., McBurney, S. P., Karkhanis, L. U., and Ross, T. M. (2006) Virus-like particles: designing an effective AIDS vaccine Methods 40, 98-117
67. Deml, L., Kratochwil, G., Osterrieder, N., Knuchel, R., Wolf, H., and Wagner, R. (1997) Increased incorporation of chimeric human immunodeficiency virus type 1 gp120 proteins into Pr55gag virus-like particles by an Epstein-Barr virus gp220/350-derived transmembrane domain Virology 235, 10-25
68. Young, K. R., Smith, J. M., and Ross, T. M. (2004) Characterization of a DNA vaccine expressing a human immunodeficiency virus-like particle Virology 327, 262-272
69. Haffar, O., Garrigues, J., Travis, B., Moran, P., Zarling, J., and Hu, S. L. (1990) Human immunodeficiency virus-like, nonreplicating, gag-env particles assemble in a recombinant vaccinia virus expression system J. Virol. 64, 2653-2659
70. Deml, L., Schirmbeck, R., Reimann, J., Wolf, H., and Wagner, R. (1997) Recombinant human immunodeficiency Pr55gag virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies Virology 235, 26-39
71. McBurney, S. P., Young, K. R., and Ross, T. M. (2007) Membrane embedded HIV-1 envelope on the surface of a virus-like particle elicits broader immune responses than soluble envelopes Virology 358, 334-346
72. Skountzou, I., Quan, F. S., Gangadhara, S., Ye, L., Vzorov, A., Selvaraj, P., Jacob, J., Compans, R. W., and Kang, S. M. (2007) Incorporation of glycosylphosphatidylinositol-anchored granulocyte-macrophage colony-stimulating factor or CD40 ligand enhances immunogenicity of chimeric simian immunodeficiency virus-like particles J. Virol. 81, 1083-1094
73. Elgueta, R., Benson, M. J., de Vries, V. C., Wasiuk, A., Guo, Y., and Noelle, R. J. (2009) Molecular mechanism and function of CD40/CD40L engagement in the immune system Immunol. Rev. 229, 152-172
74. Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., Muramatsu, S., and Steinman, R. M. (1992) Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor J. Exp. Med. 176, 1693-1702
75. Yao, Q., Vuong, V., Li, M., and Compans, R. W. (2002) Intranasal immunization with SIV virus-like particles (VLPs) elicits systemic and mucosal immunity Vaccine 20, 2537-2545
76. Yao, Q., Bu, Z., Vzorov, A., Yang, C., and Compans, R. W. (2003) Virus-like particle and DNA-based candidate AIDS vaccines Vaccine 21, 638-643
77. ONeill, E., Martinez, I., Villinger, F., Rivera, M., Gascot, S., Colon, C., Arana, T., Sidhu, M., Stout, R., Montefiori, D. C., Martinez, M., Ansari, A. A., Israel, Z. R., and Kraiselburd, E. (2002) Protection by SIV VLP DNA prime/protein boost following mucosal SIV challenge is markedly enhanced by IL-12/GM-CSF co-administration J. Med. Primatol. 31, 217-227
78. Kang, S. M. and Compans, R. W. (2003) Enhancement of mucosal immunization with virus-like particles of simian immunodeficiency virus J. Virol. 77, 3615-3623
79. Speth, C., Bredl, S., Hagleitner, M., Wild, J., Dierich, M., Wolf, H., Schroeder, J., Wagner, R., and Deml, L. (2008) Human immunodeficiency virus type-1 (HIV-1) Pr55gag virus-like particles are potent activators of human monocytes Virology 382, 46-58
80. Sailaja, G., Skountzou, I., Quan, F. S., Compans, R. W., and Kang, S. M. (2007) Human immunodeficiency virus-like particles activate multiple types of immune cells Virology 362, 331-341
81. Szecsi, J., Boson, B., Johnsson, P., Dupeyrot-Lacas, P., Matrosovich, M., Klenk, H. D., Klatzmann, D., Volchkov, V., and Cosset, F. L. (2006) Induction of neutralising antibodies by virus-like particles harbouring surface proteins from highly pathogenic H5N1 and H7N1 influenza viruses Virol. J. 3, 70
82. Bach, P., Kamphuis, E., Odermatt, B., Sutter, G., Buchholz, C. J., and Kalinke, U. (2007) Vesicular stomatitis virus glycoprotein displaying retrovirus-like particles induce a type I IFN receptor-dependent switch to neutralizing IgG antibodies J. Immunol. 178, 5839-5847
83. Bellier, B., Dalba, C., Clerc, B., Desjardins, D., Drury, R., Cosset, F. L., Collins, M., and Klatzmann, D. (2006) DNA vaccines encoding retrovirus-based virus-like particles induce efficient immune responses without adjuvant Vaccine 24, 2643-2655
84. Venneti, S. (2010) Prion diseases Clin. Lab. Med. 30, 293-309
85. Orgogozo, J. M., Gilman, S., Dartigues, J. F., Laurent, B., Puel, M., Kirby, L. C., Jouanny, P., Dubois, B., Eisner, L., Flitman, S., Michel, B. F., Boada, M., Frank, A., and Hock, C. (2003) Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization Neurology 61, 46-54
86. Bornemann, K. D. and Staufenbiel, M. (2000) Transgenic mouse models of Alzheimers disease Ann. N. Y. Acad. Sci. 908, 260-266